Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.Circulation. 2001; 103: 1759-1764
- Echocardiographic predictors of mortality in patients with advanced heart failure: the BEST Trial.J Am Coll Cardiol. 2005; 45: 1064-1071
- Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.Am J Cardiol. 2003; 91: 538-543
- Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic cardiomyopathy.Heart. 2011; 97: 1675-1680
- Influence of mitral regurgitation repair on survival in the Surgical Treatment for Ischemic Heart Failure Trial.Circulation. 2012; 125: 2639-2648
- Ischemic mitral regurgitation on the threshold of a solution from paradoxes to unifying concepts.Circulation. 2005; 112: 745-758
- Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies.Circulation. 1997; 96: 1826-1834
- Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry.Circulation. 1997; 96: 1999-2008
- Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction: evidence for increased valve tethering.J Am Coll Cardiol. 1998; 32: 398-404
- Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation. Real-time three-dimensional echocardiography study.Circulation. 2003; 107: 1135-1140
- Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial).Am J Cardiol. 2013; 112: 1812-1818
- Core lab analysis of baseline echocardiographic studies in the STICH Trial and recommendation for use of echocardiography in future clinical trials.J Am Soc Echocardiogr. 2012; 25: 327-336
- Mechanism of dynamic regurgitation orifice area variation in functional mitral regurgitation.J Am Coll Cardiol. 1999; 33: 538-545
- Effect of afterload reduction on vena contracta width in mitral regurgitation: a nitroprusside echocardiography study.J Am Coll Cardiol. 1998; 32: 427-431
- Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity.JACC Cardiovasc Imaging. 2010; 3: 235-243
- Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial.J Am Coll Cardiol. 2015; 65: 1078-1088
- Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience.JACC Cardiovasc Imaging. 2008; 1: 695-704
- Direct measurement of vena contracta area by real-time 3-dimensional echocardiography for assessing severity of mitral regurgitation.Am J Cardiol. 2009; 104: 978-983
- Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance.JACC Cardiovasc Imaging. 2009; 2: 1245-1252
- Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging.Circ Cardiovasc Imaging. 2010; 3: 694-700
- Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography.Circ Cardiovasc Imaging. 2011; 4: 506-513
- Quantitation of mitral regurgitation.Circulation. 2012; 126: 2005-2017
- Defining severe mitral regurgitation: emphasis on an integrated approach.J Am Coll Cardiol. 2014; 64: 2792-2801
This work was supported by Grants RO1HL72430 , UO1HL69015 , UO1HL60913 and UO5HL69010 from National Heart, Lung, and Blood Institute , National Institutes of Health. The views expressed in this manuscript do not necessarily reflect those of the NIH or NHLBI.
See page 917 for disclosure information.